Atea Pharmaceuticals (AVIR) to Release Quarterly Earnings on Tuesday wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Free Report) CEO Jean-Pierre Sommadossi sold 56,910 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $3.85, for a total value of $219,103.50. Following the sale, the chief executive officer now owns 116,557 shares of the company’s […]
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Free Report) insider Andrea Corcoran sold 15,843 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $3.84, for a total value of $60,837.12. Following the sale, the insider now owns 670,208 shares of the company’s stock, valued […]
Auour Investments LLC bought a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 177,000 shares of the company’s stock, valued at approximately $662,000. Auour Investments LLC owned about 0.21% of […]
Sectoral Asset Management Inc. bought a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 281,403 shares of the company’s stock, valued at approximately $1,354,000. Several other institutional investors and hedge […]